agilon health, inc. Lease, Cost
agilon health, inc. (AGL) reported Lease, Cost of $5.03 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-25.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2025-02-25
- agilon health, inc. lease, cost for fiscal 2024 was $5.03M, a 3.84% increase from fiscal 2023.
- agilon health, inc. lease, cost for fiscal 2023 was $4.84M, a 7.21% decline from fiscal 2022.
- agilon health, inc. lease, cost for fiscal 2022 was $5.21M, a 11.77% increase from fiscal 2021.
- agilon health, inc. lease, cost for fiscal 2021 was $4.67M, a 9.04% decline from fiscal 2020.
| Period end | Lease, Cost 12 month | Lease, Cost 12 month as first filed |
|---|---|---|
| 2024-12-31 | $5.03M 10-K · filed 2025-02-25 | |
| 2023-12-31 | $4.84M 10-K · filed 2025-02-25 | |
| 2022-12-31 | $5.21M 10-K · filed 2025-02-25 | $6.15M 10-K · filed 2023-03-01 |
| 2021-12-31 | $4.67M 10-K · filed 2024-02-27 | $5.80M 10-K · filed 2022-03-03 |
| 2020-12-31 | $5.13M 10-K · filed 2023-03-01 | |
| 2019-12-31 | $3.79M 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |